> The anticholinergic activity of oxybutynin is increased by concurrent use of other ANTICHOLINERGICS or medicinal products with anticholinergic activity, such as AMANTADINE and other anticholinergic antiparkinsonian medicinal products (e.g. BIPERIDEN, LEVODOPA), antihistamines, ANTIPSYCHOTICS (e.g. phenothiazines, butyrophenones, CLOZAPINE), QUINIDINE, tricyclic ANTIDEPRESSANTS, ATROPINE and related compounds like atropinic antispasmodics, DIPYRIDAMOLE. 
